Oritain hits half a billion, but faces Companies Office scrutiny

Oritain hits half a billion, but faces Companies Office scrutiny
Grant Cochrane and director John Key discuss counterfeiting issues. (Image: Oritain)
Brent Melville
Dunedin company Oritain, which specialises in origin tracing and is valued at $558 million, may have to disclose its earnings.Last week, the biotech firm completed a US$57m (NZ$90m) raise, in a series C round led by London venture capital firm Highland Europe, which valued it at just over half a billion dollars.But while its foundation is about traceability, the firm's earnings remain opaque. It doesn’t report its financials in NZ, despite "officially" being overseas owned from December 2021. Under the Companies Ac...

More Finance

Todd Corporation: the reset
Finance

Todd Corporation: the reset

Legacy gas assets will give way to a focus on solar electricity generation.

Pattrick Smellie 13 Dec 2024
Kiwibank won't bring banking Revolut-ion
Finance

Kiwibank won't bring banking Revolut-ion

Forget Kiwibank. Revolut is the force big banks will have to reckon with, expert says.

FMA to oversee ‘regulatory sandbox’ for fintechs
Finance

FMA to oversee ‘regulatory sandbox’ for fintechs

The initiative aims to speed up financial services innovation and regulation in NZ.

Ben Moore 12 Dec 2024
Todd Corp: what went wrong?
Finance

Todd Corp: what went wrong?

A dividend freeze as the family empire rebuilds for the future.

Pattrick Smellie 12 Dec 2024